Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Triumeq 5 mg/60 mg/30 mg dispersible tablets

Active Ingredient:
abacavir sulfate , dolutegravir sodium , lamivudine
Company:  
ViiV Healthcare UK Ltd See contact details
ATC code: 
J05AR13
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{external_link}

Abacavir Hypersensitivity Website for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
Abacavir Hypersensitivity Website for Healthcare Professionals

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

ViiV Healthcare UK Ltd
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
+44 (0)800 221 441